Signaling through CD31 protects endothelial cells from apoptosis
P C Evans1, E R Taylor, P J Kilshaw
1Molecular Immunology Programme, The Babraham Institute, Cambridge, UK.
Insights
Signaling through CD31 (platelet-endothelial cell adhesion molecule-1) protects endothelial cells from apoptosis. This process involves up-regulating protective genes like A20 and A1, crucial for long-term graft survival.
Area of Science:
- Immunology
- Cell Biology
- Vascular Biology
Background:
- Endothelial damage contributes to chronic rejection.
- Protective genes (A20, A1, bcl-xl, HO-1) in endothelium correlate with graft survival.
- Overexpression of these genes protects endothelial cells from apoptosis and inflammation via NF-kappaB inactivation.
Purpose of the Study:
- To investigate the role of CD31 (platelet-endothelial cell adhesion molecule-1) signaling in endothelial cell protection.
- To determine if CD31 cross-linking influences the expression of protective genes and transcription factors.
Main Methods:
- Utilized a monoclonal antibody (LCI-4) to cross-link CD31 on cultured endothelial cells.
- Assessed endothelial cell apoptosis following serum starvation.
- Measured mRNA levels of A20 and A1.
- Analyzed the activation of transcription factor Sp-1.
Main Results:
- Treatment with LCI-4 protected serum-starved endothelial cells from apoptosis.
- CD31 cross-linking elevated A20 and A1 mRNA levels.
- CD31 signaling activated the transcription factor Sp-1.
Conclusions:
- Signaling through CD31 on endothelial cells confers protection from apoptosis.
- This protection is associated with the up-regulation of protective molecules A20 and A1.
- CD31-mediated signaling may represent a therapeutic target for preventing chronic rejection.
Abstract:
Endothelial damage has been implicated in the pathogenesis of chronic rejection. Conversely, expression of protective genes [including A20, A1, bcl-xl, and hemoxygenase-1 (HO-1)] in the endothelium has been associated with long-term graft survival. Overexpression of protective genes in cultured endothelial cells confers protection from apoptosis and prevents expression of inflammatory molecules through inactivation of NF-kappaB. CD31 (PECAM-1) expressed at endothelial cell junctions is ligated by leukocytes during transendothelial migration. Our laboratory has recently shown that cross-linking CD31 using a monoclonal antibody (LCI-4) triggers signaling events in endothelial cells. In this study, we demonstrate that treatment with LCI-4 protected serum-starved endothelial cells from apoptosis. CD31 cross-linking also led to elevation of A20 and A1 mRNA levels and activation of the transcription factor Sp-1. In summary, signaling through CD31 on endothelial cells leads to protection from apoptosis in association with up-regulation of two protective molecules, A20 and A1.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Cellular Injury V: Apoptosis and Autophagy
